Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 5/2012

01-05-2012 | Rapid Communication

Delayed formation of FancD2 foci in glioma stem cells treated with ionizing radiation

Authors: Enrico Cappelli, Donatella Vecchio, Guido Frosina

Published in: Journal of Cancer Research and Clinical Oncology | Issue 5/2012

Login to get access

Abstract

Background

Glioblastoma multiforme (WHO grade IV) is a highly lethal brain tumor. Its malignancy is in part due to cell populations refractory to radiotherapy and chemotherapy, which in some patients display stem properties (glioma stem cells—GSC). We and others have recently shown that a major mechanism of resistance of GSC to therapies resides in their slow proliferation that in turn is linked to constitutive activation of the DNA damage response. FancD2, a central player of the Fanconi anemia pathway, is induced when replication forks stall at DNA damage sites.

Methods

We have analyzed the kinetics of FancD2 induction in two glioma cell lines with pronounced (Borru) and poor (DR177) stem phenotypes, by fluorescence analysis of nuclear foci.

Results

FancD2 activation was significantly delayed in Borru, consistent with the slow replication fork progression in these cells. On the contrary, no significant difference between Borru and DR177 was observed for pH2AX nuclear foci formation that hallmarks a number of DNA structure variations including double-strand breaks.

Conclusion

GSC display reduced FancD2 activation following radiation damage, most probably due to their elongated cell cycle.
Literature
go back to reference Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G (2009) BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 29:8884–8896PubMedCrossRef Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G (2009) BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 29:8884–8896PubMedCrossRef
go back to reference Bogliolo M, Lyakhovich A, Callen E, Castella M, Cappelli E, Ramirez MJ, Creus A, Marcos R, Kalb R, Neveling K, Schindler D, Surralles J (2007) Histone H2AX and fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J 26:1340–1351PubMedCrossRef Bogliolo M, Lyakhovich A, Callen E, Castella M, Cappelli E, Ramirez MJ, Creus A, Marcos R, Kalb R, Neveling K, Schindler D, Surralles J (2007) Histone H2AX and fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J 26:1340–1351PubMedCrossRef
go back to reference Bolderson E, Richard DJ, Zhou BB, Khanna KK (2009) Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. Clin Cancer Res 15:6314–6320PubMedCrossRef Bolderson E, Richard DJ, Zhou BB, Khanna KK (2009) Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. Clin Cancer Res 15:6314–6320PubMedCrossRef
go back to reference Kaneko Y, Sakakibara S, Imai T, Suzuki A, Nakamura Y, Sawamoto K, Ogawa Y, Toyama Y, Miyata T, Okano H (2000) Musashi1: An evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci 22:139–153PubMedCrossRef Kaneko Y, Sakakibara S, Imai T, Suzuki A, Nakamura Y, Sawamoto K, Ogawa Y, Toyama Y, Miyata T, Okano H (2000) Musashi1: An evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci 22:139–153PubMedCrossRef
go back to reference Moldovan GL, D’Andrea AD (2009) How the fanconi anemia pathway guards the genome. Annu Rev Genet 43:223–249PubMedCrossRef Moldovan GL, D’Andrea AD (2009) How the fanconi anemia pathway guards the genome. Annu Rev Genet 43:223–249PubMedCrossRef
go back to reference Raso A, Vecchio D, Cappelli E, Ropolo M, Poggi A, Nozza P, Biassoni R, Mascelli S, Capra V, Kalfas F, Severi P, Frosina G (2012) Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double strand breaks-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein. Brain Pathol. doi:10.1111/j.1750-3639.2012.00566.x Raso A, Vecchio D, Cappelli E, Ropolo M, Poggi A, Nozza P, Biassoni R, Mascelli S, Capra V, Kalfas F, Severi P, Frosina G (2012) Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double strand breaks-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein. Brain Pathol. doi:10.​1111/​j.​1750-3639.​2012.​00566.​x
go back to reference Ropolo M, Daga A, Griffero F, Foresta M, Casartelli G, Zunino A, Poggi A, Cappelli E, Zona G, Spaziante R, Corte G, Frosina G (2009) Comparative analysis of DNA repair in stem and nonstem glioma cell cultures. Mol Cancer Res 7:383–392PubMedCrossRef Ropolo M, Daga A, Griffero F, Foresta M, Casartelli G, Zunino A, Poggi A, Cappelli E, Zona G, Spaziante R, Corte G, Frosina G (2009) Comparative analysis of DNA repair in stem and nonstem glioma cell cultures. Mol Cancer Res 7:383–392PubMedCrossRef
go back to reference Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D’Andrea AD (2002) S-phase-specific interaction of the fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100:2414–2420PubMedCrossRef Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D’Andrea AD (2002) S-phase-specific interaction of the fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100:2414–2420PubMedCrossRef
go back to reference Tumini E, Plevani P, Muzi-Falconi M, Marini F (2011) Physical and functional crosstalk between fanconi anemia core components and the GINS replication complex. DNA Repair (Amst) 10:149–158CrossRef Tumini E, Plevani P, Muzi-Falconi M, Marini F (2011) Physical and functional crosstalk between fanconi anemia core components and the GINS replication complex. DNA Repair (Amst) 10:149–158CrossRef
go back to reference Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ (2010) Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma. CA Cancer J Clin 60:166–193PubMedCrossRef Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ (2010) Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma. CA Cancer J Clin 60:166–193PubMedCrossRef
go back to reference Wan F, Zhang S, Xie R, Gao B, Campos B, Herold-Mende C, Lei T (2010) The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research. Brain Pathol 20:877–889PubMed Wan F, Zhang S, Xie R, Gao B, Campos B, Herold-Mende C, Lei T (2010) The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research. Brain Pathol 20:877–889PubMed
go back to reference Yuan F, El Hokayem J, Zhou W, Zhang Y (2009) FANCI protein binds to DNA and interacts with FANCD2 to recognize branched structures. J Biol Chem 284:24443–24452PubMedCrossRef Yuan F, El Hokayem J, Zhou W, Zhang Y (2009) FANCI protein binds to DNA and interacts with FANCD2 to recognize branched structures. J Biol Chem 284:24443–24452PubMedCrossRef
Metadata
Title
Delayed formation of FancD2 foci in glioma stem cells treated with ionizing radiation
Authors
Enrico Cappelli
Donatella Vecchio
Guido Frosina
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 5/2012
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-012-1217-z

Other articles of this Issue 5/2012

Journal of Cancer Research and Clinical Oncology 5/2012 Go to the issue